Mangoceuticals Inc
NASDAQ:MGRX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Mangoceuticals Inc
Operating Income
Mangoceuticals Inc
Operating Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
M
|
Mangoceuticals Inc
NASDAQ:MGRX
|
Operating Income
-$19.2m
|
CAGR 3-Years
-113%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Walgreens Boots Alliance Inc
NASDAQ:WBA
|
Operating Income
$3.4B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-3%
|
|
Mangoceuticals Inc
Glance View
Mangoceuticals, Inc. engages in developing, marketing, and selling men’s wellness products and services via a telemedicine platform. The company is headquartered in Dallas, Texas. The company went IPO on 2023-03-21. The firm has developed and is in the process of preparing to commercially market a brand of erectile dysfunction (ED) product under the brand name Mango. The Company’s Mango ED product includes the ingredients, such as Tadalafil (10 milligrams (mg)), Oxytocin (100 International units (IU)) and L-Arginine (50mg), and Tadalafil (20mg), Oxytocin (100IU) and L-Arginine (50mg). The firm connects consumers to licensed healthcare professionals through its Website at www.MangoRX.com for the provision of care via telehealth through its customer portal and provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including its Mango ED product.
See Also
What is Mangoceuticals Inc's Operating Income?
Operating Income
-19.2m
USD
Based on the financial report for Dec 31, 2025, Mangoceuticals Inc's Operating Income amounts to -19.2m USD.
What is Mangoceuticals Inc's Operating Income growth rate?
Operating Income CAGR 3Y
-113%
Over the last year, the Operating Income growth was -120%. The average annual Operating Income growth rates for Mangoceuticals Inc have been -113% over the past three years .
